INVESTOR CENTRE

 HOME /INVESTOR CENTRE

Biomics Biopharma Limited
PROSPECTUS
ACN 613 499 184

BEFORE DOWNLOADING, PRINTING OR VIEWING THE PROSPECTUS AND SUPPLEMENTARY PROSPECTUS, YOU MUST CAREFULLY READ THE TERMS SET OUT IN THIS NOTICE.

The Prospectus and Supplementary Prospectus are important documents that should be read in their entirety. If you have any doubts as to how to deal with them, you should consult your legal, financial or other professional adviser. By accessing the Prospectus and Supplementary Prospectus (by clicking on the link below) you acknowledge that you have read and accept the terms set out in this notice.

 

Biomics Biopharma Limited (“Company”) lodged the prospectus (“Prospectus”) and supplementary prospectus (“Supplementary Prospectus”) with the Australian Securities and Investment Commission (“ASIC”) for an offer of up to 80,000,000 ordinary fully paid shares (“New Shares”) to raise up to A$16 million (subject to a minimum subscription of $13 million). Neither ASIC nor ASX Limited, nor any of their officers, take any responsibility for the contents of the Prospectus and Supplementary Prospectus.

 

If you are accessing an electronic copy of the Prospectus and Supplementary Prospectus, please ensure that you have received the entire Prospectus and Supplementary Prospectus accompanied by the Supplementary Application Form. If you have not, please contact the Company and the Company will send you, for free, either a hard copy or a further electronic copy of the Prospectus and Supplementary Prospectus or both.

 

The offer constituted by an electronic version of the Prospectus and Supplementary Prospectus is only available to persons receiving an electronic version of the Prospectus and Supplementary Prospectus within Australia. The Prospectus and Supplementary Prospectus does not constitute an offer in any place in which, or to any person to whom, it would not be lawful to make such an offer. The Corporations Act prohibits any person from passing on to another person the Supplementary Application Form unless it is attached to or accompanied by a complete and unaltered version of the Prospectus and Supplementary Prospectus. The Company will not accept a completed Supplementary Application Form if it has reason to believe that the Applicant has not received a complete and unaltered copy of the Prospectus and Supplementary Prospectus. Any person may obtain a hard copy of the Prospectus and Supplementary Prospectus by contacting the Company prior to the Closing Date for the offer.

 

No person is authorised to give any information or to make any representation in relation to the Offer which is not contained in the Prospectus and Supplementary Prospectus and any such information may not be relied upon as having been authorised by the Company.

 

By clicking here you agree to all the above. Continue to Prospectus and Supplementary Prospectus.

  • © Copyright Biomics Biopharma 2017
  •   76 Changxing Road, E&T Development Area, Nantong,
    P.R. China 226016 (Zip Code)